Kingcold L Tablet contains Levocetirizine 5mg and Montelukast 10mg, combining an antihistamine and a leukotriene receptor antagonist for the effective management of allergic conditions. Levocetirizine, a third-generation non-sedating antihistamine, selectively inhibits peripheral H1 receptors, thereby alleviating symptoms such as sneezing, rhinorrhea, nasal congestion, and pruritus associated with allergic rhinitis and chronic urticaria. Montelukast acts by blocking leukotriene D4 receptors in the airways, reducing inflammation, bronchoconstriction, and mucus production, making it beneficial in the treatment of asthma and allergic rhinitis. The synergistic action of these agents provides comprehensive relief from allergic symptoms by targeting multiple inflammatory pathways. Kingcold L Tablet is indicated for patients suffering from seasonal allergic rhinitis, perennial allergic rhinitis, and asthma prophylaxis, particularly when monotherapy is insufficient. It is generally well tolerated, with common adverse effects including headache, fatigue, and gastrointestinal disturbances. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision. This combination therapy offers an improved quality of life by controlling allergic symptoms effectively and preventing exacerbations.